Predictive Technology Group Inc banner

Predictive Technology Group Inc
OTC:PRED

Watchlist Manager
Predictive Technology Group Inc Logo
Predictive Technology Group Inc
OTC:PRED
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $30k

Multiples-Based Value

PRED doesn't have a meaningful market cap.

There is not enough data to reliably calculate the multiples-based value of PRED.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PRED Multiples-Based Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

PRED Competitors Multiples
Predictive Technology Group Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Predictive Technology Group Inc
OTC:PRED
30k USD 0 -0 -0.2 -0.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 690 872.8 -160 127.7 -194 446.1 -192 227.3
US
Abbvie Inc
NYSE:ABBV
380.1B USD 6.2 90.8 15 20.8
US
Exact Sciences Corp
NASDAQ:EXAS
362.4B USD 111.6 -1 741.9 951.3 -107.4
US
Amgen Inc
NASDAQ:AMGN
190.4B USD 5.2 24.7 14.3 14.3
US
Gilead Sciences Inc
NASDAQ:GILD
174.1B USD 5.9 20.5 12.8 15.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.6B USD 9.5 28.7 21.6 22.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 091 -533.6 -581 -565.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.2B USD 5.7 18.2 13.7 15.6
AU
CSL Ltd
ASX:CSL
68.5B AUD 3.1 34 11.3 14.2
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.8 -66.6 -60.1
P/E Multiple
Earnings Growth PEG
US
Predictive Technology Group Inc
OTC:PRED
Average P/E: 36.1
Negative Multiple: -0
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 127.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
90.8
97%
0.9
US
Exact Sciences Corp
NASDAQ:EXAS
Negative Multiple: -1 741.9 N/A N/A
US
Amgen Inc
NASDAQ:AMGN
24.7
20%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
20.5
16%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.7
17%
1.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -533.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.2
13%
1.4
AU
CSL Ltd
ASX:CSL
34
10%
3.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Predictive Technology Group Inc
OTC:PRED
Average EV/EBITDA: 148.6
Negative Multiple: -0.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 446.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15
12%
1.3
US
Exact Sciences Corp
NASDAQ:EXAS
951.3
261%
3.6
US
Amgen Inc
NASDAQ:AMGN
14.3
10%
1.4
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
9%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.6
16%
1.3
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.7
18%
0.8
AU
CSL Ltd
ASX:CSL
11.3
7%
1.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.6 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Predictive Technology Group Inc
OTC:PRED
Average EV/EBIT: 17.2
Negative Multiple: -0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 227.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
20.8
23%
0.9
US
Exact Sciences Corp
NASDAQ:EXAS
Negative Multiple: -107.4 N/A N/A
US
Amgen Inc
NASDAQ:AMGN
14.3
3%
4.8
US
Gilead Sciences Inc
NASDAQ:GILD
15.8
13%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.6
17%
1.3
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.6
23%
0.7
AU
CSL Ltd
ASX:CSL
14.2
10%
1.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.1 N/A N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett